White Blood Cells in Urine of Catheterized Patients
Pyuria (WBCs in urine) should NOT be used as the sole criterion to obtain a urine culture or initiate treatment in catheterized patients, as it has poor sensitivity (37%) for catheter-associated UTI (CAUTI) and is commonly present even without infection.
Clinical Significance of Pyuria in Catheterized Patients
Poor Diagnostic Value
- Pyuria is nearly universal in catheterized patients and poorly correlates with actual infection 1
- While pyuria (>10 WBC/μL or >5 per high-power field) has 90% specificity for CAUTI, it only has 37% sensitivity, meaning most patients with CAUTI do not have significant pyuria 1
- Routine catheter changes themselves cause a statistically significant increase in urinary WBCs without changing bacterial identity or colony counts 2
Organism-Specific Patterns
The degree of pyuria varies significantly by pathogen 1:
- Gram-negative bacilli produce the strongest pyuria response (mean 121 WBC/μL)
- Gram-positive cocci (coagulase-negative staphylococci, enterococci) produce minimal pyuria (mean 39 WBC/μL)
- Yeasts produce even less pyuria (mean 25 WBC/μL)
When to Suspect CAUTI
Clinical Indicators That Matter
Do NOT screen asymptomatic catheterized patients for bacteriuria or pyuria 3. Only investigate when patients have 4:
- New onset or worsening fever
- Rigors
- Altered mental status
- Malaise or lethargy (with no other identified cause)
- Flank pain or costovertebral angle tenderness
- Acute hematuria
- Pelvic discomfort
- In recently decatheterized patients: dysuria, urgency, frequency, or suprapubic pain/tenderness
Key Pitfall
Most patients with CAUTI are asymptomatic and do not have associated fever 1. The presence of pyuria alone does not warrant treatment.
Management Approach
When Symptomatic CAUTI is Suspected
- Obtain urine culture and susceptibility testing before initiating empiric therapy 4
- For complicated UTI with systemic symptoms, use empiric combination therapy 4:
- Amoxicillin plus aminoglycoside, OR
- Second-generation cephalosporin plus aminoglycoside, OR
- Intravenous third-generation cephalosporin
- Avoid fluoroquinolones empirically if the patient is from a urology department or has used fluoroquinolones in the last 6 months 4
- Tailor therapy based on culture results 4
- Treatment duration: 7-14 days (14 days for men when prostatitis cannot be excluded) 4
What NOT to Do
- Do NOT screen for asymptomatic bacteriuria in catheterized patients (except pregnant women and those undergoing endoscopic urologic procedures with mucosal trauma) 3
- Do NOT routinely change catheters as infection prevention 3
- Do NOT use systemic antimicrobials as prophylaxis 3
- Do NOT use pyuria as the sole criterion to obtain urine culture 1
Prevention Focus
The most important risk factor for CAUTI is catheterization duration 4. Remove catheters as soon as clinically appropriate 3.